You have searched for "Hospitalizations"
Showing 1-10 of 56
NEW YORK: Even with half the U.S. vaccinated, Covid-19 continues to kill people faster than guns, car crashes and influenza combined, according to a review of mortality data.
The plan to roll out Merck & Co's promising antiviral pill to treat COVID-19 risks repeating the inequities of vaccine distribution, potentially leaving the nations with the greatest need once again at the back of the line, international health groups say.
Regardless of lifestyle and other health-related factors, heavier people were more likely than lean ones to be hospitalized for a variety of conditions, according to an Australian study.
NEW YORK: Here is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus
NEW YORK: Commercial airlines around the world canceled more than 4,500 flights over the Christmas weekend, as a mounting wave of COVID-19 infections driven by the Omicron variant created greater uncertainty and misery for holiday travelers.
The World Health Organization said on Monday it hopes to review safety data on Sanofi's dengue vaccine this month, while the Philippines ordered an investigation of its now suspended massive immunization programme after the French drugmaker said it could actually worsen the disease in some cases. It is approved but not yet launched in Malaysia, Honduras, Australia, Argentina, Venezuela, Bolivia, Bangladesh and Cambodia.
SACRAMENTO, California (AP): California officials are warily awaiting the next round of state revenue figures, concerned that their latest budget-balancing efforts may not be enough to end a seemingly endless stream of deficits.
CHICAGO (AP): Global fears over bird flu have sent sales soaring for an antiviral drug once dismissed as a commercial dud, but the two companies responsible for the drug are locked in a bitter court battle over profits.
LONDON: Expectations are building for a new heart failure drug from Novartis viewed as a likely multibillion-dollar seller, with two surveys of cardiologists published on Tuesday highlighting its potential. A large clinical trial with LCZ696 was stopped early in March because the benefit to patients was overwhelmingly positive. Just how good the drug was will be disclosed at a medical meeting in Spain at the end of this month.